封面
市場調查報告書
商品編碼
1482439

塑身設備市場:依產品類型、最終用戶、地區:全球產業分析、規模、佔有率、成長、趨勢、預測,2024-2031 年

Body Contouring Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日期: | 出版商: Persistence Market Research | 英文 302 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

持久性市場研究對全球塑身設備市場進行深入分析,深入瞭解市場動態、成長動力、課題和新興趨勢。該報告提供了詳細的數據和統計數據以引導市場格局,並為利害關係人提供全面的指南。

預計全球塑身設備市場在 2024 年至 2031 年預測期內將顯著成長,複合年增長率為 15%。該市場預計將從 2024 年的 18 億美元擴大到 2031 年的 48 億美元。

重要見解

  • 預計市場規模(2024年):18億美元
  • 預計市值(2031年)48億美元
  • 全球市場成長率(2024-2031年複合年增長率):15%

塑身設備市場 – 研究範圍

身體輪廓設備包括一系列旨在塑造和重新定義身體輪廓的非侵入性和微創手術。這些設備針對腹部、大腿、上臂和臀部等區域,並列出了減脂、緊膚和減少脂肪團的解決方案。

人們對外觀美感的日益重視,加上美容手術技術的進步,正在推動對塑身設備的需求。肥胖率上升、可支配收入增加以及美容護理意識不斷增強等因素推動了市場的成長。

市場驅動因素:

身體輪廓設備市場受到多種因素的推動,例如世界上肥胖和超重人口的增加。隨著人們尋求塑造更優美體形的方法,對非手術身體輪廓手術的需求不斷增加。射頻、超音波和冷凍溶脂設備等技術的進步為傳統外科手術提供了有效且安全的替代方案。

此外,人口老化和對更年輕外表的渴望正在推動對緊膚和減少脂肪團治療的需求。此外,融資選擇的可用性和醫療旅遊的盛行進一步促進了市場的成長。

市場限制因素:

儘管成長軌跡充滿希望,但輪廓設備市場仍面臨一定的課題。對非侵入性手術的安全性和有效性的擔憂可能會阻礙其進入市場,尤其是在謹慎的消費者中。整容手術的監管監督和報銷限制也為市場擴張帶來了課題。

此外,與先進的輪廓設備和治療相關的高成本可能會限制某些患者群體的使用。此外,注射和外科手術等替代療法的出現可能會轉移非侵入性身體輪廓設備的市場佔有率。

市場機會:

塑身設備市場存在許多創新和擴張的機會。技術進步,例如結合不同能源的多模式方法,可以改善治療結果和患者滿意度。此外,臉部年輕化和陰道年輕化等超越傳統身體輪廓的應用正在擴大市場範圍。

從地區來看,由於可支配收入的增加、生活方式的改變以及美容程序意識的提高,亞太和拉丁美洲新興市場具有強勁的成長潛力。策略合作夥伴關係、合併和收購使公司能夠擴大其產品組合和地理分佈並提高市場滲透率。

本報告解決的關鍵問題

  • 2024年至2031年塑身設備市場的預期複合年增長率是多少?
  • 推動塑身設備市場成長的關鍵因素是什麼?
  • 哪個地區在塑身設備市場中佔最大的市場佔有率?
  • 全球塑身設備市場的主要參與者有哪些?
  • 主要參與者正在採取哪些策略來維持塑身設備市場的成長?

目錄

第一章執行摘要

第二章市場概況

  • 市場範圍/分類
  • 市場定義/範圍/限制

第三章市場背景

  • 市場動態
  • 情景預測
  • 機會圖分析
  • 產品生命週期分析
  • 供應鏈分析
  • 投資可行性矩陣
  • 價值鏈分析
  • PESTLE 與 Porter 分析
  • 監管狀況
  • 區域母公司市場展望
  • 生產與消費統計
  • 進出口統計

第四章全球塑身設備市場分析

  • 2019-2023 年過去市場規模(百萬美元)與數量(單位)分析
  • 2024-2031 年當前市場規模價值(百萬美元)和數量(單位)的分析和預測
  • 同比增長趨勢分析
  • 絕對量機會分析

第五章全球塑身設備市場類型分析

  • 簡介/主要發現
  • 2019-2023 年歷史市場規模(百萬美元)和數量(單位)分析(依類型)
  • 2024-2031 年依類型劃分的當前市場規模價值(百萬美元)和數量(件)的分析和預測
    • 無創和微創設備
    • 侵入性裝置
  • 2019-2023年依類型年成長趨勢分析
  • 2024-2031 年依類型劃分的絕對數量機會分析

第 6 章:依應用類型劃分的全球塑身設備市場分析

  • 簡介/主要發現
  • 2019-2023 年歷史市場規模(百萬美元)和數量(單位)分析(依應用類型)
  • 2024-2031 年依應用類型劃分的當前市場規模價值(百萬美元)和數量(單位)的分析和預測
    • 非手術皮膚再生
    • 非手術緊膚
    • 橘皮組織治療
    • 抽脂術
    • 其他
  • 2019-2023 年依應用類型劃分的年成長趨勢分析
  • 2024-2031 年依應用類型劃分的絕對貨幣機會分析

第七章塑身儀市場區域分析

  • 介紹
  • 2019-2023 年歷史市場規模(百萬美元)和數量(單位)分析(依地區)
  • 2024-2031 年依地區劃分的當前市場規模價值(百萬美元)和數量(單位)分析和預測
    • 北美
    • 拉丁美洲
    • 歐洲
    • 亞太地區
    • 中東/非洲
  • 區域市場吸引力分析

第八章北美塑身設備市場分析:依國家

第九章拉丁美洲塑身設備市場分析:依國家分類

第10章歐洲塑身設備市場分析:依國家分類

第十一章亞太塑身設備市場分析:依國家

第十二章中東和非洲塑身設備市場分析:依國家/地區

第十三章 主要國家塑身儀市場分析

  • 美國
  • 加拿大
  • 巴西
  • 墨西哥
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 中國
  • 日本
  • 韓國
  • 新加坡
  • 泰國
  • 印度尼西亞
  • 澳大利亞
  • 紐西蘭
  • 海灣合作委員會國家
  • 南非
  • 以色列

第14章市場結構分析

  • 比賽儀表板
  • 競爭標桿
  • 主要參與者的市場佔有率分析

第 15 章 競爭分析

  • 衝突詳情
    • Cynosure, Inc.
    • Alma Lasers
    • Allergan Plc
    • Merz Pharma Gmbh
    • Candela Medical Ltd.
    • Solta Medical Bausch Health Companies, Inc.
    • Lutronic Corporation
    • InMode Ltd
    • Fotona
    • Sofwave Medical LTD
    • Sciton Inc
    • Lumenis

第 16 章所使用的假設與縮寫詞

第17章研究方法論

簡介目錄
Product Code: PMRREP33175

Persistence Market Research conducts an in-depth analysis of the global Body Contouring Devices Market, offering insights into market dynamics, growth drivers, challenges, and emerging trends. This report serves as a comprehensive guide for stakeholders, providing detailed data and statistics to navigate the market landscape.

The global body contouring devices market is anticipated to witness substantial growth during the forecast period from 2024 to 2031, with a projected CAGR of 15%. The market is estimated to expand from USD 1.8 billion in 2024 to USD 4.8 billion by 2031.

Key Insights:

  • Estimated Market Value (2024): USD 1.8 Billion
  • Projected Market Value (2031): USD 4.8 Billion
  • Global Market Growth Rate (CAGR 2024 to 2031): 15%

Body Contouring Devices Market - Report Scope:

Body contouring devices encompass a range of non-invasive and minimally invasive procedures designed to reshape and redefine the body's contours. These devices target areas such as abdomen, thighs, arms, and buttocks, offering solutions for fat reduction, skin tightening, and cellulite reduction.

The growing emphasis on aesthetic appearance, coupled with technological advancements in cosmetic procedures, drives the demand for body contouring devices. Factors such as rising obesity rates, increasing disposable income, and growing awareness about cosmetic treatments contribute to market growth.

Market Growth Drivers:

The body contouring devices market is propelled by several factors, including the rising prevalence of obesity and overweight populations worldwide. As individuals seek ways to achieve a more sculpted physique, the demand for non-surgical body contouring procedures increases. Technological advancements, such as radiofrequency, ultrasound, and cryolipolysis-based devices, offer effective and safer alternatives to traditional surgical procedures.

Moreover, the expanding aging population, coupled with the desire for youthful appearance, drives demand for skin tightening and cellulite reduction treatments. Additionally, the availability of financing options and the proliferation of medical tourism further contribute to market growth.

Market Restraints:

Despite its promising growth trajectory, the body contouring devices market faces certain challenges. Concerns regarding the safety and efficacy of non-invasive procedures may hinder market adoption, particularly among cautious consumers. Regulatory scrutiny and reimbursement limitations for cosmetic procedures also pose challenges for market expansion.

Moreover, the high cost associated with advanced body contouring devices and treatments may limit access for certain patient demographics. Additionally, the emergence of alternative treatments, such as injectables and surgical procedures, may divert market share from non-invasive body contouring devices.

Market Opportunities:

The body contouring devices market presents several opportunities for innovation and expansion. Advancements in technology, such as multi-modal approaches combining different energy sources, enhance treatment outcomes and patient satisfaction. Furthermore, expanding applications beyond traditional body contouring, such as facial rejuvenation and vaginal rejuvenation, broaden the market scope.

Geographically, emerging markets in Asia Pacific and Latin America offer significant growth potential due to increasing disposable income, changing lifestyles, and growing awareness about aesthetic procedures. Strategic partnerships, mergers, and acquisitions enable companies to expand their product portfolios and geographic presence, driving market penetration.

Key Questions Addressed in the Report:

  • What is the Expected Value CAGR of the Body Contouring Devices Market from 2024 to 2031?
  • What are the Key Factors Driving the Growth of the Body Contouring Devices Market?
  • Which Region Holds the Largest Market Share in the Body Contouring Devices Market?
  • Who are the Key Players in the Global Body Contouring Devices Market?
  • What Strategies are Adopted by Leading Companies to Sustain Growth in the Body Contouring Devices Market?

Competitive Landscape and Business Strategies:

Prominent players in the body contouring devices market include Alma Lasers, Ltd., Cynosure, Inc. (a subsidiary of Hologic, Inc.), Syneron Medical Ltd. (a subsidiary of Apax Partners), and Lumenis Ltd. These companies focus on product innovation, research and development, and strategic collaborations to maintain market leadership.

Key strategies adopted by leading players include launching advanced body contouring devices with enhanced safety profiles and superior efficacy. Moreover, investment in clinical research and marketing initiatives aimed at increasing patient awareness and education is crucial for market expansion.

Key Companies Profiled:

  • Alma Lasers, Ltd.
  • Cynosure, Inc. (a subsidiary of Hologic, Inc.)
  • Syneron Medical Ltd. (a subsidiary of Apax Partners)
  • Lumenis Ltd.
  • Cutera, Inc.
  • Venus Concept Ltd.
  • Solta Medical, Inc. (a subsidiary of Bausch Health Companies Inc.)
  • InMode Ltd.
  • BTL Industries Inc.
  • Zimmer MedizinSysteme GmbH

Body Contouring Devices Market Segmentation:

By Type

  • Non-invasive and Minimally Invasive Devices
  • Invasive Devices

By Application type

  • Nonsurgical skin Resurfacing
  • Nonsurgical skin tightening
  • Cellulite treatment
  • Liposuction
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Product Life Cycle Analysis
  • 3.5. Supply Chain Analysis
    • 3.5.1. Supply Side Participants and their Roles
      • 3.5.1.1. Producers
      • 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
      • 3.5.1.3. Wholesalers and Distributors
    • 3.5.2. Value Added and Value Created at Node in the Supply Chain
    • 3.5.3. List of Raw Material Suppliers
    • 3.5.4. List of Existing and Potential Buyer's
  • 3.6. Investment Feasibility Matrix
  • 3.7. Value Chain Analysis
    • 3.7.1. Profit Margin Analysis
    • 3.7.2. Wholesalers and Distributors
    • 3.7.3. Retailers
  • 3.8. PESTLE and Porter's Analysis
  • 3.9. Regulatory Landscape
    • 3.9.1. By Key Regions
    • 3.9.2. By Key Countries
  • 3.10. Regional Parent Market Outlook
  • 3.11. Production and Consumption Statistics
  • 3.12. Import and Export Statistics

4. Global Body Contouring Devices Market Analysis 2019-2023 and Forecast, 2024-2031

  • 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2024-2031
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Type, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Type, 2024-2031
    • 5.3.1. Non-invasive and Minimally Invasive Devices
    • 5.3.2. Invasive Devices
  • 5.4. Y-o-Y Growth Trend Analysis By Type, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Type, 2024-2031

6. Global Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Application Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application Type, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application Type, 2024-2031
    • 6.3.1. Nonsurgical Skin Resurfacing
    • 6.3.2. Nonsurgical Skin Tightening
    • 6.3.3. Cellulite Treatment
    • 6.3.4. Liposuction
    • 6.3.5. Others
  • 6.4. Y-o-Y Growth Trend Analysis By Application Type, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Application Type, 2024-2031

7. Global Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Region

  • 7.1. Introduction
  • 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2019-2023
  • 7.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2024-2031
    • 7.3.1. North America
    • 7.3.2. Latin America
    • 7.3.3. Europe
    • 7.3.4. Asia Pacific
    • 7.3.5. MEA
  • 7.4. Market Attractiveness Analysis By Region

8. North America Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 8.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 8.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
    • 8.2.1. By Country
      • 8.2.1.1. U.S.
      • 8.2.1.2. Canada
    • 8.2.2. By Type
    • 8.2.3. By Application Type
  • 8.3. Market Attractiveness Analysis
    • 8.3.1. By Country
    • 8.3.2. By Type
    • 8.3.3. By Application Type
  • 8.4. Key Takeaways

9. Latin America Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
    • 9.2.1. By Country
      • 9.2.1.1. Brazil
      • 9.2.1.2. Mexico
      • 9.2.1.3. Rest of Latin America
    • 9.2.2. By Type
    • 9.2.3. By Application Type
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Type
    • 9.3.3. By Application Type
  • 9.4. Key Takeaways

10. Europe Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
    • 10.2.1. By Country
      • 10.2.1.1. Germany
      • 10.2.1.2. U.K.
      • 10.2.1.3. France
      • 10.2.1.4. Spain
      • 10.2.1.5. Italy
      • 10.2.1.6. Rest of Europe
    • 10.2.2. By Type
    • 10.2.3. By Application Type
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Type
    • 10.3.3. By Application Type
  • 10.4. Key Takeaways

11. Asia Pacific Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
    • 11.2.1. By Country
      • 11.2.1.1. China
      • 11.2.1.2. Japan
      • 11.2.1.3. South Korea
      • 11.2.1.4. Singapore
      • 11.2.1.5. Thailand
      • 11.2.1.6. Indonesia
      • 11.2.1.7. Australia
      • 11.2.1.8. New Zealand
      • 11.2.1.9. Rest of Asia Pacific
    • 11.2.2. By Type
    • 11.2.3. By Application Type
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Type
    • 11.3.3. By Application Type
  • 11.4. Key Takeaways

12. MEA Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
    • 12.2.1. By Country
      • 12.2.1.1. GCC Countries
      • 12.2.1.2. South Africa
      • 12.2.1.3. Israel
      • 12.2.1.4. Rest of MEA
    • 12.2.2. By Type
    • 12.2.3. By Application Type
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Type
    • 12.3.3. By Application Type
  • 12.4. Key Takeaways

13. Key Countries Body Contouring Devices Market Analysis

  • 13.1. U.S.
    • 13.1.1. Pricing Analysis
    • 13.1.2. Market Share Analysis, 2024
      • 13.1.2.1. By Type
      • 13.1.2.2. By Application Type
  • 13.2. Canada
    • 13.2.1. Pricing Analysis
    • 13.2.2. Market Share Analysis, 2024
      • 13.2.2.1. By Type
      • 13.2.2.2. By Application Type
  • 13.3. Brazil
    • 13.3.1. Pricing Analysis
    • 13.3.2. Market Share Analysis, 2024
      • 13.3.2.1. By Type
      • 13.3.2.2. By Application Type
  • 13.4. Mexico
    • 13.4.1. Pricing Analysis
    • 13.4.2. Market Share Analysis, 2024
      • 13.4.2.1. By Type
      • 13.4.2.2. By Application Type
  • 13.5. Germany
    • 13.5.1. Pricing Analysis
    • 13.5.2. Market Share Analysis, 2024
      • 13.5.2.1. By Type
      • 13.5.2.2. By Application Type
  • 13.6. U.K.
    • 13.6.1. Pricing Analysis
    • 13.6.2. Market Share Analysis, 2024
      • 13.6.2.1. By Type
      • 13.6.2.2. By Application Type
  • 13.7. France
    • 13.7.1. Pricing Analysis
    • 13.7.2. Market Share Analysis, 2024
      • 13.7.2.1. By Type
      • 13.7.2.2. By Application Type
  • 13.8. Spain
    • 13.8.1. Pricing Analysis
    • 13.8.2. Market Share Analysis, 2024
      • 13.8.2.1. By Type
      • 13.8.2.2. By Application Type
  • 13.9. Italy
    • 13.9.1. Pricing Analysis
    • 13.9.2. Market Share Analysis, 2024
      • 13.9.2.1. By Type
      • 13.9.2.2. By Application Type
  • 13.10. China
    • 13.10.1. Pricing Analysis
    • 13.10.2. Market Share Analysis, 2024
      • 13.10.2.1. By Type
      • 13.10.2.2. By Application Type
  • 13.11. Japan
    • 13.11.1. Pricing Analysis
    • 13.11.2. Market Share Analysis, 2024
      • 13.11.2.1. By Type
      • 13.11.2.2. By Application Type
  • 13.12. South Korea
    • 13.12.1. Pricing Analysis
    • 13.12.2. Market Share Analysis, 2024
      • 13.12.2.1. By Type
      • 13.12.2.2. By Application Type
  • 13.13. Singapore
    • 13.13.1. Pricing Analysis
    • 13.13.2. Market Share Analysis, 2024
      • 13.13.2.1. By Type
      • 13.13.2.2. By Application Type
  • 13.14. Thailand
    • 13.14.1. Pricing Analysis
    • 13.14.2. Market Share Analysis, 2024
      • 13.14.2.1. By Type
      • 13.14.2.2. By Application Type
  • 13.15. Indonesia
    • 13.15.1. Pricing Analysis
    • 13.15.2. Market Share Analysis, 2024
      • 13.15.2.1. By Type
      • 13.15.2.2. By Application Type
  • 13.16. Australia
    • 13.16.1. Pricing Analysis
    • 13.16.2. Market Share Analysis, 2024
      • 13.16.2.1. By Type
      • 13.16.2.2. By Application Type
  • 13.17. New Zealand
    • 13.17.1. Pricing Analysis
    • 13.17.2. Market Share Analysis, 2024
      • 13.17.2.1. By Type
      • 13.17.2.2. By Application Type
  • 13.18. GCC Countries
    • 13.18.1. Pricing Analysis
    • 13.18.2. Market Share Analysis, 2024
      • 13.18.2.1. By Type
      • 13.18.2.2. By Application Type
  • 13.19. South Africa
    • 13.19.1. Pricing Analysis
    • 13.19.2. Market Share Analysis, 2024
      • 13.19.2.1. By Type
      • 13.19.2.2. By Application Type
  • 13.20. Israel
    • 13.20.1. Pricing Analysis
    • 13.20.2. Market Share Analysis, 2024
      • 13.20.2.1. By Type
      • 13.20.2.2. By Application Type

14. Market Structure Analysis

  • 14.1. Competition Dashboard
  • 14.2. Competition Benchmarking
  • 14.3. Market Share Analysis of Top Players
    • 14.3.1. By Regional
    • 14.3.2. By Type
    • 14.3.3. By Application Type

15. Competition Analysis

  • 15.1. Competition Deep Dive
    • 15.1.1. Cynosure, Inc.
      • 15.1.1.1. Overview
      • 15.1.1.2. Product Portfolio
      • 15.1.1.3. Profitability by Market Segments
      • 15.1.1.4. Sales Footprint
      • 15.1.1.5. Strategy Overview
        • 15.1.1.5.1. Marketing Strategy
        • 15.1.1.5.2. Product Strategy
        • 15.1.1.5.3. Channel Strategy
    • 15.1.2. Alma Lasers
      • 15.1.2.1. Overview
      • 15.1.2.2. Product Portfolio
      • 15.1.2.3. Profitability by Market Segments
      • 15.1.2.4. Sales Footprint
      • 15.1.2.5. Strategy Overview
        • 15.1.2.5.1. Marketing Strategy
        • 15.1.2.5.2. Product Strategy
        • 15.1.2.5.3. Channel Strategy
    • 15.1.3. Allergan Plc
      • 15.1.3.1. Overview
      • 15.1.3.2. Product Portfolio
      • 15.1.3.3. Profitability by Market Segments
      • 15.1.3.4. Sales Footprint
      • 15.1.3.5. Strategy Overview
        • 15.1.3.5.1. Marketing Strategy
        • 15.1.3.5.2. Product Strategy
        • 15.1.3.5.3. Channel Strategy
    • 15.1.4. Merz Pharma Gmbh
      • 15.1.4.1. Overview
      • 15.1.4.2. Product Portfolio
      • 15.1.4.3. Profitability by Market Segments
      • 15.1.4.4. Sales Footprint
      • 15.1.4.5. Strategy Overview
        • 15.1.4.5.1. Marketing Strategy
        • 15.1.4.5.2. Product Strategy
        • 15.1.4.5.3. Channel Strategy
    • 15.1.5. Candela Medical Ltd.
      • 15.1.5.1. Overview
      • 15.1.5.2. Product Portfolio
      • 15.1.5.3. Profitability by Market Segments
      • 15.1.5.4. Sales Footprint
      • 15.1.5.5. Strategy Overview
        • 15.1.5.5.1. Marketing Strategy
        • 15.1.5.5.2. Product Strategy
        • 15.1.5.5.3. Channel Strategy
    • 15.1.6. Solta Medical Bausch Health Companies, Inc.
      • 15.1.6.1. Overview
      • 15.1.6.2. Product Portfolio
      • 15.1.6.3. Profitability by Market Segments
      • 15.1.6.4. Sales Footprint
      • 15.1.6.5. Strategy Overview
        • 15.1.6.5.1. Marketing Strategy
        • 15.1.6.5.2. Product Strategy
        • 15.1.6.5.3. Channel Strategy
    • 15.1.7. Lutronic Corporation
      • 15.1.7.1. Overview
      • 15.1.7.2. Product Portfolio
      • 15.1.7.3. Profitability by Market Segments
      • 15.1.7.4. Sales Footprint
      • 15.1.7.5. Strategy Overview
        • 15.1.7.5.1. Marketing Strategy
        • 15.1.7.5.2. Product Strategy
        • 15.1.7.5.3. Channel Strategy
    • 15.1.8. InMode Ltd
      • 15.1.8.1. Overview
      • 15.1.8.2. Product Portfolio
      • 15.1.8.3. Profitability by Market Segments
      • 15.1.8.4. Sales Footprint
      • 15.1.8.5. Strategy Overview
        • 15.1.8.5.1. Marketing Strategy
        • 15.1.8.5.2. Product Strategy
        • 15.1.8.5.3. Channel Strategy
    • 15.1.9. Fotona
      • 15.1.9.1. Overview
      • 15.1.9.2. Product Portfolio
      • 15.1.9.3. Profitability by Market Segments
      • 15.1.9.4. Sales Footprint
      • 15.1.9.5. Strategy Overview
        • 15.1.9.5.1. Marketing Strategy
        • 15.1.9.5.2. Product Strategy
        • 15.1.9.5.3. Channel Strategy
    • 15.1.10. Sofwave Medical LTD
      • 15.1.10.1. Overview
      • 15.1.10.2. Product Portfolio
      • 15.1.10.3. Profitability by Market Segments
      • 15.1.10.4. Sales Footprint
      • 15.1.10.5. Strategy Overview
        • 15.1.10.5.1. Marketing Strategy
        • 15.1.10.5.2. Product Strategy
        • 15.1.10.5.3. Channel Strategy
    • 15.1.11. Sciton Inc
      • 15.1.11.1. Overview
      • 15.1.11.2. Product Portfolio
      • 15.1.11.3. Profitability by Market Segments
      • 15.1.11.4. Sales Footprint
      • 15.1.11.5. Strategy Overview
        • 15.1.11.5.1. Marketing Strategy
        • 15.1.11.5.2. Product Strategy
        • 15.1.11.5.3. Channel Strategy
    • 15.1.12. Lumenis
      • 15.1.12.1. Overview
      • 15.1.12.2. Product Portfolio
      • 15.1.12.3. Profitability by Market Segments
      • 15.1.12.4. Sales Footprint
      • 15.1.12.5. Strategy Overview
        • 15.1.12.5.1. Marketing Strategy
        • 15.1.12.5.2. Product Strategy
        • 15.1.12.5.3. Channel Strategy

16. Assumptions & Acronyms Used

17. Research Methodology